ADVERTISEMENT

Amanta Healthcare IPO Day 2: Check Subscription Status, Latest GMP And More

A pharmaceutical company specialising in sterile products like large and small volume parenterals and some medical devices, Amanta Healthcare is holding a Rs 126 crore IPO.

Amanta Healthcare IPO
Amanta Healthcare IPO was fully subscribed hours within launch on Monday (Photo:  LinkedIn/@Amanta Healthcare Ltd.)
Show Quick Read
Summary is AI Generated. Newsroom Reviewed

Amanta Healthcare Ltd.'s initial public offering entered its second day of subscription. The issue was fully subscribed within hours of launch on Monday, led by demand from retail investors.

A pharmaceutical company specialising in sterile products like large and small volume parenterals and some medical devices, Amanta Healthcare is holding a Rs 126 crore IPO.

The entire IPO is a fresh issue of shares, with no offer-for-sale component. The price band is set at Rs 120 to Rs 126 apiece, with the IPO closing on Wednesday, Sept. 3.

Amanta Healthcare is set to utilise the IPO proceeds to boost its capex plans. The minimum amount of investment required by a retail investor is Rs 14,994. Investors can bid for a minimum of 119 shares and in multiples thereof.

The tentative date of allotment of shares to IPO investors is Sept. 4. Amanta Healthcare will likely list on the BSE and NSE on Sept. 9.

Opinion
Amanta Healthcare IPO GMP Trends As Mainboard Issue Fully Subscribed On Day 1

Amanta Healthcare IPO: Key Details

  • Open date: Sept. 1

  • Close date: Sept. 3

  • Allotment date: Sept. 4

  • Price Band: Rs 120-126

  • Tentative Listing date: Sept. 9

  • IPO size: Rs 126 crore

  • Fresh issue: 1 crore shares aggregating to Rs 126 crore.

  • Minimum bid: Lot size of 119 shares

Amanta Healthcare GMP

The grey market premium of Amanta Healthcare IPO fell to Rs 25 as of 5:01 p.m. on InvestorGain. The GMP price indicated a 19.84% listing gain as indicated by the implied listing price of Rs 151.

Note: GMP or grey market price is not an official price quote for the stock and is based on speculation.

Opinion
Upcoming IPO: Leap India Files Draft Papers With SEBI To Raise Rs 2,400 Crore Via Fresh Issue, OFS
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit